Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT01002547
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 105 participants
- Registry
-
NCT01002547
-
- Other papers using this trial's data
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01002547. Randomized; triple masking; primary purpose treatment. Start 2010-06-24 (actual); primary completion 2016-09-30 (actual). Results posted on 2018-09-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
- Acronym
- VA NASH
- Condition
- Nonalcoholic Steatohepatitis
- Intervention (Drug)
- pioglitazone-placebo
- Intervention (Drug)
- pioglitazone
- Intervention (Dietary supplement)
- Vitamin E
- Intervention (Drug)
- pioglitazone-placebo
- Intervention (Dietary supplement)
- Vitamin E
- Intervention (Drug)
- Vitamin E-placebo
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct01002547- Content hash
04040ec2839846033751490be5adc336cf0c937ed7b05e4f5a9741173fcb18fb